Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Microbiome in Cystic Fibrosis Pulmonary Disease
Alice Françoise, Geneviève Héry-Arnaud
Genes (2020) Vol. 11, Iss. 5, pp. 536-536
Open Access | Times Cited: 85

Showing 26-50 of 85 citing articles:

The respiratory tract microbiome, the pathogen load, and clinical interventions define severity of bacterial pneumonia
Ana Elena Pérez‐Cobas, Christophe Ginévra, Christophe Rusniok, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 9, pp. 101167-101167
Open Access | Times Cited: 7
Regulation effect of the intestinal flora and intervention strategies targeting the intestinal flora in alleviation of pulmonary fibrosis development
Jianquan GUO, Liyang YANG
Bioscience of Microbiota Food and Health (2024) Vol. 43, Iss. 4, pp. 293-299
Open Access | Times Cited: 2
An integrated metaproteomics workflow for studying host-microbe dynamics in bronchoalveolar lavage samples applied to cystic fibrosis disease
Monica Kruk, Subina Mehta, Kevin Murray, et al.
mSystems (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 2
RNA-Seq reveals that Pseudomonas aeruginosa mounts growth medium-dependent competitive responses when sensing diffusible cues from Burkholderia cenocepacia
Anne Leinweber, Clémentine Laffont, Martina Lardi, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Microbiome-Mucosal Immunity Nexus: Driving Forces in Respiratory Disease Progression
Young Chae Park, Soo Yeon Choi, Y.-H. Cha, et al.
The Journal of Microbiology (2024) Vol. 62, Iss. 9, pp. 709-725
Closed Access | Times Cited: 2
Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy
Justyna Milczewska, Zulfiya Syunyaeva, Aleksandra Żabińska-Jaroń, et al.
European Respiratory Review (2024) Vol. 33, Iss. 174, pp. 240068-240068
Open Access | Times Cited: 2
Interactions of Bacteriophages and Bacteria at the Airway Mucosa: New Insights Into the Pathophysiology of Asthma
Panagiota Tzani-Tzanopoulou, Dimitrios Skliros, Spyridon Megremis, et al.
Frontiers in Allergy (2021) Vol. 1
Open Access | Times Cited: 17
Lung Microbiome in Cystic Fibrosis
Filippo Scialò, Felice Amato, Gustavo Cernera, et al.
Life (2021) Vol. 11, Iss. 2, pp. 94-94
Open Access | Times Cited: 16
An observational study of anaerobic bacteria in cystic fibrosis lung using culture dependant and independent approaches
Claudie Lamoureux, Charles-Antoine Guilloux, Clémence Beauruelle, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 16
An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota
Shaoshuai Li, Yang Zhou, Dongmei Yan, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1774-1774
Open Access | Times Cited: 12
The gut-lung axis in the CFTR modulator era
Florian Lussac-Sorton, Éléna Charpentier, Sébastien Imbert, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and Progression
Vanessa G. P. Souza, Aisling Forder, Michelle E. Pewarchuk, et al.
Cells (2023) Vol. 12, Iss. 24, pp. 2801-2801
Open Access | Times Cited: 6
Gut Dysbiosis in Children with Cystic Fibrosis: Development, Features and the Role of Gut–Lung Axis on Disease Progression
Ilaria Testa, Oliviero Crescenzi, Susanna Esposito
Microorganisms (2022) Vol. 11, Iss. 1, pp. 9-9
Open Access | Times Cited: 9
Airway bacterial community composition in persons with advanced cystic fibrosis lung disease
Christina S. Thornton, Lisa A. Carmody, Linda M. Kalikin, et al.
Journal of Cystic Fibrosis (2023) Vol. 22, Iss. 4, pp. 623-629
Closed Access | Times Cited: 5
Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders
Filippo Scialò, Maria Vitale, Vito D’Agnano, et al.
Lung (2023) Vol. 201, Iss. 5, pp. 455-466
Closed Access | Times Cited: 5
Potential systemic effects of acquired CFTR dysfunction in COPD
Marc Miravitlles, Gerard J. Criner, Marcus Mall, et al.
Respiratory Medicine (2023) Vol. 221, pp. 107499-107499
Closed Access | Times Cited: 5
Human Respiratory and Gut Microbiomes—Do They Really Contribute to Respiratory Health?
Juliana Durack, C. Christophersen
Frontiers in Pediatrics (2020) Vol. 8
Open Access | Times Cited: 13
Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung
David F. Woods, Stephanie Flynn, José A. Caparrós‐Martín, et al.
Antibiotics (2021) Vol. 10, Iss. 7, pp. 766-766
Open Access | Times Cited: 12
Quick and wide-range taxonomical repertoire establishment of the cystic fibrosis lung microbiota by tandem mass spectrometry on sputum samples
P. Hardouin, Olivier Pible, Hélène Marchandin, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 8
Lung and Gut Microbiota Changes Associated with Pseudomonas aeruginosa Infection in Mouse Models of Cystic Fibrosis
Giovanni Bacci, Alice S. Rossi, Federica Armanini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12169-12169
Open Access | Times Cited: 11
Organic Acids and Their Salts Potentiate the Activity of Selected Antibiotics against Pseudomonas aeruginosa Biofilms Grown in a Synthetic Cystic Fibrosis Sputum Medium
Xuerui Bao, Mona Bové, Tom Coenye
Antimicrobial Agents and Chemotherapy (2021) Vol. 66, Iss. 1
Open Access | Times Cited: 11
A novel in vitro model to study prolonged Pseudomonas aeruginosa infection in the cystic fibrosis bronchial epithelium
Meghan June Hirsch, Emily M. Hughes, Molly Easter, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288002-e0288002
Open Access | Times Cited: 4
Normal human microbiota and dysbiosis: Implications for health and disease
Dragana D. Božić, Marina Milenković, Jelena Antić‐Stanković, et al.
Arhiv za farmaciju (2024) Vol. 74, Iss. 3, pp. 1-22
Open Access | Times Cited: 1
Interactions between Pseudomonas aeruginosa and six opportunistic pathogens cover a broad spectrum from mutualism to antagonism
Clémentine Laffont, Tobias Wechsler, Rolf Kümmerli
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Heryk Motta, Júlia Catarina Vieira Reuwsaat, Fernanda Cortez Lopes, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1

Scroll to top